Literature DB >> 27272453

The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center.

S K Bae1, T Gushima1, N Saito2, I Yamanaka2, T Shimokawa2, Y Matsuo2, S Yoshida2, I Kawano2, H Henzan2, S Shimoda3, T Eto2, K Takahashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27272453     DOI： 10.1038/bmt.2016.149

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease.

Authors:  P Seth; A A Alrajhi; I Kagevi; M A Chaudhary; E Colcol; E Sahovic; M Aljurf; M Gyger
Journal:  Bone Marrow Transplant       Date:  2002-08       Impact factor: 5.483

Review 2.  Management of patients with hepatitis B who require immunosuppressive therapy.

Authors:  Jessica P Hwang; Anna S-F Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-19       Impact factor: 46.802

3.  Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication.

Authors:  J H Hoofnagle; R J Gerety; L Y Ni; L F Barker
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

4.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

Review 5.  Immunopathogenesis of hepatitis B virus infection.

Authors:  J Judy Chang; Sharon R Lewin
Journal:  Immunol Cell Biol       Date:  2006-11-28       Impact factor: 5.126

6.  Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation.

Authors:  A Knöll; S Boehm; J Hahn; E Holler; W Jilg
Journal:  Bone Marrow Transplant       Date:  2004-05       Impact factor: 5.483

Review 7.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

8.  Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc.

Authors:  N Dhédin; C Douvin; M Kuentz; M F Saint Marc; O Reman; C Rieux; F Bernaudin; F Norol; C Cordonnier; D Bobin; J M Metreau; J P Vernant
Journal:  Transplantation       Date:  1998-09-15       Impact factor: 4.939

9.  Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

Authors:  Junko Tanaka; Junko Kumagai; Keiko Katayama; Yutaka Komiya; Masaaki Mizui; Retsuji Yamanaka; Kou Suzuki; Yuzo Miyakawa; Hiroshi Yoshizawa
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

10.  Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.

Authors:  Feng-Qin Hou; Liu-Wei Song; Quan Yuan; Lin-Lin Fang; Sheng-Xiang Ge; Jun Zhang; Ji-Fang Sheng; Dong-Ying Xie; Jia Shang; Shu-Huan Wu; Yong-Tao Sun; Shao-Feng Wei; Mao-Rong Wang; Mo-Bin Wan; Ji-Dong Jia; Guang-Han Luo; Hong Tang; Shu-Chen Li; Jun-Qi Niu; Wei-Dong Zhou; Li Sun; Ning-Shao Xia; Gui-Qiang Wang
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556
View more
  2 in total

1.  HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.

Authors:  Olympia E Anastasiou; Foteini Almpani; Anke Herrmann; Guido Gerken; Markus Ditschkowski; Sandra Ciesek
Journal:  Hepatol Commun       Date:  2017-11-06

Review 2.  Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yibo Wu; He Huang; Yi Luo
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.